Target Price | $125.88 |
Price | $124.25 |
Potential |
1.31%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target TransMedics Group, Inc. 2026 .
The average TransMedics Group, Inc. target price is $125.88.
This is
1.31%
register free of charge
$146.00
17.51%
register free of charge
$103.00
17.10%
register free of charge
|
|
A rating was issued by 10 analysts: 7 Analysts recommend TransMedics Group, Inc. to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the TransMedics Group, Inc. stock has an average upside potential 2026 of
1.31%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 441.54 | 580.27 |
82.74% | 31.42% | |
EBITDA Margin | 8.54% | 20.57% |
3,396.65% | 140.91% | |
Net Margin | 8.03% | 10.59% |
177.52% | 31.86% |
10 Analysts have issued a sales forecast TransMedics Group, Inc. 2025 . The average TransMedics Group, Inc. sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an TransMedics Group, Inc. EBITDA forecast 2025. The average TransMedics Group, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 TransMedics Group, Inc. Analysts have issued a net profit forecast 2025. The average TransMedics Group, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.01 | 1.82 |
231.17% | 80.20% | |
P/E | 68.38 | |
EV/Sales | 7.59 |
7 Analysts have issued a TransMedics Group, Inc. forecast for earnings per share. The average TransMedics Group, Inc. EPS is
This results in the following potential growth metrics and future valuations:
TransMedics Group, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Locked
➜
Locked
|
Locked | May 09 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | May 09 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
Needham |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Needham |
Locked
➜
Locked
|
Locked | Mar 26 2025 |
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
Needham |
Locked
➜
Locked
|
Locked | Feb 05 2025 |
Analyst Rating | Date |
---|---|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 09 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
May 09 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 29 2025 |
Locked
Needham:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Needham:
Locked
➜
Locked
|
Mar 26 2025 |
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 11 2025 |
Locked
Needham:
Locked
➜
Locked
|
Feb 05 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.